[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100552139":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":25,"locations":25,"responsibleParty":29,"collaborators":25,"id":31,"slug":32,"hasResults":33,"nctId":34,"briefTitle":35,"officialTitle":35,"acronym":25,"eligibilityCriteria":36,"healthyVolunteers":33,"sex":37,"minAge":38,"maxAge":25,"enrollmentInfo":39,"targetDuration":25,"studyType":42,"phases":43,"briefSummary":45,"conditions":46,"keywords":48,"overallStatus":54,"whyStopped":25,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":25},{"fullName":5,"class":6},"Assuta Ashdod Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Placebo","PLACEBO_COMPARATOR","Participants will receive 100 ml of saline alone.",[13],"Drug: Sodium Chloride 0.9% Inj",{"label":15,"type":16,"description":17,"interventionNames":18},"Oxytocin","EXPERIMENTAL","Participants will receive an intravenous infusion of 8 units of oxytocin diluted in 100 ml of saline.",[19,13],"Drug: Oxytocin",[21,26],{"type":22,"name":15,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Women undergoing dilation and curettage, who meet the eligibility criteria for the study, will be divided into two groups. They will receive the assigned medication at the beginning of the procedure, after cervical dilation but before using suction curettage.\n\nGroup 1: Participants will receive 100 ml of saline alone. Group 2: Participants will receive an intravenous infusion of 8 units of oxytocin diluted in 100 ml of saline.",[15],null,{"type":22,"name":27,"description":23,"armGroupLabels":28,"otherNames":25},"Sodium Chloride 0.9% Inj",[15,9],{"type":30,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100552139","oxytocin-effectiveness-in-first-trimester-dilatation-and-curettage-100552139",false,"NCT06469203","Oxytocin Effectiveness in First Trimester Dilatation and Curettage","Inclusion Criteria:\n\n* All patients admitted to the OBGYN Assuta Ashdod Hospital for elective surgical termination of pregnancy due to missed miscarriages in the first trimester, with gestational age range of 6.0 to 11.6 weeks.\n\nPatients aged 18 years and older who are capable to provide informed consent.\n\nExclusion Criteria:\n\n* individual intolerance to oxytocin\n* mullerian anomalies\n* Fibroid uterus\n* thrombophilia or coagulation disorders\n* cardiovascular disease","FEMALE","18 Years",{"count":40,"type":41},160,"ESTIMATED","INTERVENTIONAL",[44],"NA","The aim of this study is to investigate the impact of oxytocin on perioperative blood loss during the D\\&C procedure, as well as to assess early and late complications associated with it's use.",[47],"Missed Abortion",[49,50,51,52,53],"missed abortion","vaginal bleeding","dilation and curretage","pregnancy termination","oxytocin","NOT_YET_RECRUITING","2024-08-12",{"date":57,"type":58},"2024-08-13","ACTUAL",{"date":60,"type":41},"2024-09-01",{"date":62,"type":41},"2026-06",{"name":5,"class":6}]